TickerFacts.

Integra Lifesciences Holdings Corp (IART): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$50.38M
Year ended 2025-12-31
$85.33M
Trailing 12 months to 2026-06-30
-42.5%
3-year compound annual growth
-24.4%
5-year compound annual growth
-7.1%
10-year compound annual growth
$312.43M2008-12-31: $72.59M2009-12-31: $143.24M2010-12-31: $105.57M2011-12-31: $104.33M2012-12-31: $59.10M2013-12-31: $53.27M2014-12-31: $83.56M2015-12-31: $104.85M2016-12-31: $116.41M2017-12-31: $114.54M2018-12-31: $199.68M2019-12-31: $231.43M2020-12-31: $203.83M2021-12-31: $312.43M2022-12-31: $264.47M2023-12-31: $139.96M2024-12-31: $129.38M2025-12-31: $50.38M$50.38M
2008-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$50.38M-61.1%2026-02-26, From 2025-01-01
2024-12-31$129.38M-7.6%2026-02-26, From 2024-01-01
2023-12-31$139.96M-47.1%2026-02-26, From 2023-01-01
2022-12-31$264.47M-15.4%2025-02-25, From 2022-01-01
2021-12-31$312.43M+53.3%2024-02-28, From 2021-01-01
2020-12-31$203.83M-11.9%2023-02-22, From 2020-01-01
2019-12-31$231.43M+15.9%2022-02-24, From 2019-01-01
2018-12-31$199.68M+74.3%2021-02-23, From 2018-01-01
2017-12-31$114.54M-1.6%2020-02-21, From 2017-01-01
2016-12-31$116.41M+11.0%2019-02-26, From 2016-01-01
2015-12-31$104.85M+25.5%2018-03-01, From 2015-01-01
2014-12-31$83.56Mn/c2017-02-23, From 2014-01-01
2013-12-31$53.27M-9.9%2016-02-26, From 2013-01-01
2012-12-31$59.10M-43.4%2015-02-27, From 2012-01-01
2011-12-31$104.33M-1.2%2014-02-27, From 2011-01-01
2010-12-31$105.57M-26.3%2013-02-26, From 2010-01-01
2009-12-31$143.24M+97.3%2012-02-27, From 2009-01-01
2008-12-31$72.59Mn/a2011-02-24, From 2008-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31$50.38M-61.1%
Merit Medical Systems Inc (MMSI)2025-12-31$297.37M+34.7%
Penumbra Inc (PEN)2025-12-31$238.66M+41.7%
Teleflex Inc (TFX)2025-12-31$96.68M-68.0%
Haemonetics Corp (HAE)2026-03-28$293.22M+61.4%
ICU Medical Inc (ICUI)2025-12-31$179.85M-11.9%
Embecta Corp. (EMBC)2025-09-30$191.70M+437.0%
Tandem Diabetes Care Inc (TNDM)2025-12-31-$9.72Mn/m
Insulet Corp (PODD)2025-12-31$569.30M+32.3%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗